financetom
Business
financetom
/
Business
/
Facebook launches virtual-reality meetings app ‘Horizon Workrooms’
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Facebook launches virtual-reality meetings app ‘Horizon Workrooms’
Aug 20, 2021 8:14 AM

Facebook is trying to pull in workplace users with a new virtual-reality meetings app called Horizon Workrooms.

Workrooms lets people meet remotely in a virtual space populated by avatars. It's an app for Facebook's headset, which costs at least USD 300 and weighs a pound.

People without a headset can join with a video call. Up to 50 people can be on the call, but only 16 can be in the VR space with avatars. For the full VR experience, users need to have a Facebook account.

Facebook CEO Mark Zuckerberg is a fan of the metaverse, a vague concept that encompasses augmented and virtual reality with new ways of connecting. He expects it to be the next stage of how people experience the internet.

Virtual reality has never really taken off, even during the pandemic, when remote work became the norm for millions of office workers and made the videoconferencing service Zoom a household name.

(Edited by : Priyanka Deshpande)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca Says FDA Approved Tagrisso as Treatment of Specific Type of Non-Small Cell Lung Cancer in Adults
AstraZeneca Says FDA Approved Tagrisso as Treatment of Specific Type of Non-Small Cell Lung Cancer in Adults
Oct 3, 2024
07:38 AM EDT, 09/26/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Thursday that the US Food and Drug Administration approved Tagrisso as treatment of adult patients with a specific type of non-small cell lung cancer whose disease has not progressed after platinum-based chemoradiation therapy. The approval was based on data from a phase 3 trial, which showed that Tagrisso...
Pfizer withdraws sickle cell disease treatment on risk of complication, death
Pfizer withdraws sickle cell disease treatment on risk of complication, death
Oct 3, 2024
(Reuters) -U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks of a painful complication and deaths. Pfizer bought Oxbryta, also known as voxelotor, as part of its $5.4 billion buyout of Global Blood Therapeutics in 2022. It reported $328 million in revenues from the therapy...
Sage Therapeutics Says Biogen Discontinues Collaboration on Sage-324 Program
Sage Therapeutics Says Biogen Discontinues Collaboration on Sage-324 Program
Oct 3, 2024
07:43 AM EDT, 09/26/2024 (MT Newswires) -- Sage Therapeutics ( SAGE ) said Thursday that Biogen (BIIB) has terminated its rights under the partnership and license agreement with the company for the Sage-324 program, effective Feb. 17. Sage said it will resume full ownership of the Sage-324 asset after termination. The companies will continue to collaborate on Zurzuvae, a US...
Market Chatter: Spirit AeroSystems to Begin Furloughs in 3 Weeks Over Boeing Strike
Market Chatter: Spirit AeroSystems to Begin Furloughs in 3 Weeks Over Boeing Strike
Oct 3, 2024
07:42 AM EDT, 09/26/2024 (MT Newswires) -- Spirit AeroSystems ( SPR ) , Boeing's ( BA ) fuselage supplier for the 737 Max, could begin furloughing employees in three weeks if the aerospace company fails to end a strike in Washington state, the Financial Times reported Thursday, citing an industry source. For now, the company is using the labor stoppage...
Copyright 2023-2026 - www.financetom.com All Rights Reserved